AP NEWS

POC Molecular Diagnostics - Worldwide Market Analysis & Forecast Through 2019-2023 with Abbott, bioMerieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, and Qiagen Leading the Competition - ResearchAndMarkets.com

January 7, 2019

DUBLIN--(BUSINESS WIRE)--Jan 7, 2019--The “Global POC Molecular Diagnostics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The POC molecular diagnostics market will register a CAGR of almost 14% by 2023.

Growing focus on technological advances to drive growth in the market

The increasing focus on the development of technologically advanced POC molecular diagnostic products will result in the augmented adoption of these products. These advanced devices decrease the workload of end-users and offer results within limited time. Therefore, to increase the efficiency and effectiveness of the results, the companies are developing advanced products.

Growing number of M&A and collaborations

Large companies are increasingly acquiring and collaborating with specialized POC molecular diagnostic companies to expand their product portfolio. Collaboration would result in the development of additional POC tests which can be offered across the globe, thereby expanding the company’s reach.

Product recalls

End-users rely on companies that provide high-quality products. When products lead to patient injury or fatalities, manufacturers wither voluntarily recall them from the market. This affects the market growth and brand image.

Key Players

Abbott bioMerieux Bio-Rad Laboratories Danaher F. Hoffmann-La Roche QIAGEN

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY APPLICATION

Market segmentation by application Comparison by application Infectious diseases - Market size and forecast 2018-2023 Oncology - Market size and forecast 2018-2023 Hematology and endocrinology - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY TECHNOLOGY

Market segmentation by technology Comparison by technology PCR (gene sequencing) - Market size and forecast 2018-2023 Microarray and hybridization - Market size and forecast 2018-2023 Market opportunity by technology

PART 09: GEOGRAPHIC LANDSCAPE

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

Growing focus on technological advances Liquid biopsy as an emerging trend Presence of government funding

PART 13: VENDOR LANDSCAPE

PART 14: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Abbott bioMerieux Bio-Rad Laboratories Danaher F. Hoffmann-La Roche QIAGEN

For more information about this report visit https://www.researchandmarkets.com/research/bmb5mw/poc_molecular?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190107005635/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Point-of-Care Diagnostics,Molecular Diagnostics

KEYWORD: ASIA PACIFIC NORTH AMERICA

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/07/2019 08:56 AM/DISC: 01/07/2019 08:56 AM

http://www.businesswire.com/news/home/20190107005635/en

AP RADIO
Update hourly